Scanning electromicrograph of a cell infected with HIV. Credit: NIAID/Flickr.

Gilead Sciences has launched a ten-year, $100m initiative, Commitment to Partnership in Addressing HIV/AIDS in Southern States (COMPASS), to address the HIV/AIDS epidemic in the US.

The firm plans to collaborate with Emory University Rollins School of Public Health, the University of Houston Graduate College of Social Work and the Southern AIDS Coalition to lead COMPASS’ corporate giving programme.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

With a focus on capacity building, knowledge sharing, mental health and trauma-informed care, and educational campaigns, the centres will identify and provide funding to local organisations.

Gilead Sciences Corporate and Medical Affairs executive vice-president Gregg Alton said: “HIV/AIDS remains an urgent public health crisis in the US and this is particularly apparent in the Southern states where rates of new infection rival those seen in the 1980s.

“In some communities, those rates are actually rising – a chilling reminder that the epidemic is far from a thing of the past.

“In some communities, those rates are actually rising – a chilling reminder that the epidemic is far from a thing of the past.”

“We recognise a collaborative effort is needed and we are very pleased to partner with local organisations that are uniquely positioned to address the epidemic on the ground.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The firm’s corporate giving programme focuses on minimising disparities, providing access, enhancing education and supporting local communities.

Through the initiative, Gilead intends to boost the reach of the organisations involved in addressing the HIV/AIDS epidemic and improving patient lives.

Based in California, the firm discovers, develops and commercialises new medicines for areas of unmet medical need and life-threatening diseases.